Accession Number: | 0001104659-21-082604 |
Date: | 2021-06-15 |
Issuer: | CYCLACEL PHARMACEUTICALS, INC. (CYCC) |
Original Submission Date: |
BARKER SAM L
C/O CYCLACEL PHARMACEUTICALS, INC.,
200 CONNELL DRIVE, SUITE 1500
BERKELEY HEIGHTS, NJ 07922
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-15 | A | 2,374 | a | $0.00 | 2,386 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 6.69 | 2021-06-15 | deemed execution date | A | 4,748 (a) | 2022-06-15 | 2031-06-15 | common stock 4,748 | $6.69 | 4,748 | direct |
ID | footnote |
---|---|
f1 | the reporting person received an award of 2,374 restricted stock units on june 15, 2021, which shall vest in full on june 15, 2022. |
f2 | these options were granted to dr. barker for his services as a member of the board of directors of cyclacel pharmaceuticals, inc. |